Anti-Ubiquitin [ZTA10-90-6]
Invented at IFOM-IEO
- Datasheet
- References (0)
- Inventor Info
Info
| Applications | IP WB |
| Antigen/Gene or Protein Targets | Ubiquitin |
| Reactivity | All |
| Relevance | Ubiquitin is a small regulatory protein that affects proteins through a process called ubiquitination. Ubiquitin can signal for protein degradation via the proteasome, alter their cellular location, affect their activity, and promote or prevent protein interactions. Ubiquitination is carried out in three main steps: activation, conjugation, and ligation, performed by ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s), and ubiquitin ligases (E3s), respectively. The result of this sequential cascade binds ubiquitin to the protein substrate. When covalently bound, ubiquitin is conjugated to target proteins via an isopeptide bond either as a monomer (monoubiquitin) or a polymer linked via different Lys residues of the ubiquitin (polyubiquitin chains). Polyubiquitin chains, when attached to a target protein, have different functions depending on the Lys residue of the ubiquitin that is linked. Inappropriate ubiquitin-mediated protein degradation has been implicated in a number of diseases, especially neurodegenerative disorders that involve protein aggregation and inclusion body formation, such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and amyotrophic lateral sclerosis (ALS), where protein misfolding may play a role. |
| Host | Mouse |
| Subclass | IgG1 kappa |
| Myeloma Used | Sp2/0 |
| Research Area | Epigenetics & Nuclear Signalling, Neurobiology, Protein Degradation |
References
There are 0 reference entries for this reagent.
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference
